This opinion cites 11 cases:
Comaper Corp. v. Antec, Inc. , 596 F.3d 1343 ( 2010 )
Kimberly-Clark Corporation v. Johnson & Johnson and Personal Products Company , 745 F.2d 1437 ( 1984 )
Forest Laboratories, Inc. v. Ivax Pharmaceuticals, Inc. , 501 F.3d 1263 ( 2007 )
Michael S. Brown, Joseph L. Goldstein, and Yuval Reiss v. Mariano Barbacid and Veeraswamy Manne , 436 F.3d 1376 ( 2006 )
Amgen Inc., Plaintiff-Cross v. Hoechst Marion Roussel, Inc. (Now Known as Aventis Pharmaceuticals, Inc.) and Transkaryotic Therapies, Inc. , 314 F.3d 1313 ( 2003 )
The Dow Chemical Company v. Astro-Valcour, Inc. , 267 F.3d 1334 ( 2001 )
Wyers v. Master Lock Co. , 616 F.3d 1231 ( 2010 )
E.I. Du Pont De Nemours & Company v. Phillips Petroleum Company, Phillips 66 Company, and Phillips Driscopipe, Inc., Defendants-Cross-Appellants , 849 F.2d 1430 ( 1988 )
Microsoft Corp. v. i4i Ltd. Partnership , 131 S. Ct. 2238 ( 2011 )
Burroughs Wellcome Co. v. Barr Laboratories, Inc., and Novopharm, Inc. And Novopharm, Ltd. , 40 F.3d 1223 ( 1994 )
KSR International Co. v. Teleflex Inc. , 127 S. Ct. 1727 ( 2007 )
